Drug recall: B-COMPLEX #3 (PF), B1-100MG, B2-2-PO4-2MG, B3-100MG, B5-2MG, B6-2MG/ML, 2ML Vials, MEDAUS PHARMACY

Class II FDA enforcement event 74466. Recall start date: 13 May 2016. Status in the FDA record: Terminated. Termination date: 16 Jun 2017.

Reason for recall, in the words of FDA

Lack of Assurance of Sterility

Class II, in the words of FDA

a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote

Medaus, Inc. started this drug recall on 13 May 2016. The firm address in the FDA record is in Birmingham, AL. FDA put the recall in Class II. FDA event 74466 has 88 product records. The first FDA enforcement report date is 20 Jul 2016. The record gives the status Terminated, with the termination date 16 Jun 2017.

FDA enforcement report The 88 product records

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.
FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on 1 Oct 2026. openFDA export of 28 Sep 2026.

Distribution

In the words of FDA.

U.S. Nationwide, Japan, and New Zealand.

Recalling firm

Medaus, Inc., Birmingham, AL.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

88 product records in the event.

FDA event 74466: product records
Recall number	Product	Quantity	Class	Status	Report date
D-1167-2016	B-COMPLEX #3 (PF), B1-100MG, B2-2-PO4-2MG, B3-100MG, B5-2MG, B6-2MG/ML, 2ML Vials, MEDAUS PHARMACY	1000 mL in Vials	Class II	Terminated	20 Jul 2016
D-1168-2016	B-COMPLEX #3 W/PRES (BENZYL ETOH 2%), B1-100MG, B2-5-PO4-2MG, B3-100MG, B5-2MG, B6-2MG/ML, 10ML Vials, MEDAUS PHARMACY	380 mL in Vials	Class II	Terminated	20 Jul 2016
D-1169-2016	B-COMPLEX (LIEBERMAN) IN NACL 0.9% (PF), B1-12.5MG, B2-5-PO4-10MG, B3-12.5MG, B5-12.5MG, B6-12.5MG/ML, 2ML Vials, MEDAUS PHARMACY	60 mL in Vials	Class II	Terminated	20 Jul 2016
D-1170-2016	B-COMPLEX WITHOUT B12 (PF) IN NACL 0.9%, B1-100MG, B2-5-PO4-2MG, B3-50MG, B5-2MG, B6-2MG/ML, In a) 2ML Vials and b) 5ML Vials, MEDAUS PHARMACY	4000 mL in Vials	Class II	Terminated	20 Jul 2016
D-1171-2016	B-COMPLEX WITHOUT B12 W/PRES (BENZYL ETOH 2%), B1-100MG, B2-5-PO4-2MG, B3-50MG, B5-2MG, B6-2MG/ML, In a) 5ML Vials and b) 10ML Vials, MEDAUS PHARMACY	955 mL in Vials	Class II	Terminated	20 Jul 2016
D-1172-2016	B-COMPLEX 50 IN NACL 0.9% (PF) B1-50MG, B2-5-PO4-5MG, B3-50MG, B5-50MG, B6-50MG/ML, 2ML Vials, MEDAUS PHARMACY	1000 mL in Vials	Class II	Terminated	20 Jul 2016
D-1173-2016	B-COMPLEX 50 IN NACL 0.9% W/PRES., (BENZYL ETOH 2%), B1-50MG, B2-5-PO4-5MG, B3-50MG, B5-50MG, B6-50MG/ML, 10ML Vials, MEDAUS PHARMACY	4000 mL in Vials	Class II	Terminated	20 Jul 2016
D-1174-2016	B-COMPLEX W/CYANO B12 W/PRES., (BENZYL ETOH 2%), B1-100MG, B2-5-PO4-2MG, B3-50MG, B5-2MG, B6-2MG, CYANO B12 1MG/ML, In a) 2ML Vials, b) 5MLVials, c) 10ML Vials, MEDAUS PHARMACY	62 mL in Vials	Class II	Terminated	20 Jul 2016
D-1175-2016	B-COMPLEX W/METHYL B12/LIDO W/PRES (BENZYL ETOH 2%), B1-100MG, B2-5-PO4-2MG, B3-50MG, B5-2MG, B6-2MG, LIDOCAINE 1%, METHYL B12 1MG/ML, In a) 1ML Vials, b) 5ML Vials, and c) 10ML Vials, MEDAUS PHARMACY	370 mL in Vials	Class II	Terminated	20 Jul 2016
D-1176-2016	CALCIUM SODIUM EDTA 300MG/ML (PF), 10ML Vials, MEDAUS PHARMACY	8500 mL in Vials	Class II	Terminated	20 Jul 2016
D-1177-2016	CESIUM CHLORIDE 600MG/ML (PF), 10ML Vials, MEDAUS PHARMACY	506 mL in Vials	Class II	Terminated	20 Jul 2016
D-1178-2016	DEXPANTHENOL 250MG/ML (PF), In a) 2ML Vials and b) 5ML Vials, MEDAUS PHARMACY	3500 mL in Vials	Class II	Terminated	20 Jul 2016
D-1179-2016	DEXPANTHENOL 250MG/ML W/PRES. (BENZALKONIUM CHL 0.01%), 10ML Vials, MEDAUS PHARMACY	1110 mL in Vials	Class II	Terminated	20 Jul 2016
D-1180-2016	DMPS 50MG/ML (PF), 5ML Vials, MEDAUS PHARMACY	1000 mL in Vials	Class II	Terminated	20 Jul 2016
D-1181-2016	DMSO 99.9 (PF), In a) 5ML Vials and b) 10ML Vials, MEDAUS PHARMACY	2218 mL in Vials	Class II	Terminated	20 Jul 2016
D-1182-2016	EDTA DISODIUM 15% (150MG/ML), 20ML Vials, MEDAUS PHARMACY	24000 mL in Vials	Class II	Terminated	20 Jul 2016
D-1183-2016	ESTRADIOLVAL 3MG/TEST CYP 35MG/ TEST PROP 35MG/ML W/PRES. (BENZYL ETOH 2%), 3ML Vials, MEDAUS PHARMACY	10 mL in Vials	Class II	Terminated	20 Jul 2016
D-1184-2016	FOLIC ACID 10MG/ML IN NACL (PF), 1ML Vials, MEDAUS PHARMACY	250 mL in Vials	Class II	Terminated	20 Jul 2016
D-1185-2016	FOLIC ACID 10MG/ML W/PRES. (METHYLPARABEN 0.05%, PROPYLPARABEN 0.025% IN NACL, 10ML Vials, MEDAUS PHARMACY	500 mL in Vials	Class II	Terminated	20 Jul 2016
D-1186-2106	GABA 50MG/ML (PF), 50ML Vials, MEDAUS PHARMACY	110 mL in Vials	Class II	Terminated	20 Jul 2016
D-1187-2016	GERMANIUM SESO 100MG/ML (PF), 10ML Vials, MEDAUS PHARMACY	49 mL in Vials	Class II	Terminated	20 Jul 2016
D-1188-2016	HYALURONIDASE 500U/ML(PF), 3ML Vials, MEDAUS PHARMACY	500 mL in Vials	Class II	Terminated	20 Jul 2016
D-1189-2016	HYDROGEN PEROXIDE 3% (PF), 5ML Vials, MEDAUS PHARMACY	1000 mL in Vials	Class II	Terminated	20 Jul 2016
D-1190-2016	HYDROXY B12 5MG/ML W/PRES (BENZALKONIUM 0.01%), 5ML Vials, MEDAUS PHARMACY	210 mL in Vials	Class II	Terminated	20 Jul 2016
D-1191-2016	HYDROXY B12 5MG/ML IN NACL 0.9% (PF), In a) 1ML Vials and b) 2ML Vials, MEDAUS PHARMACY	800 mL in Vials	Class II	Terminated	20 Jul 2016
D-1192-2016	HYDROXY B12 1000MCG/ML W/PRES (BENZALKONIUM 0.01%), 10ML Vials, MEDAUS PHARMACY	7000 mL in Vials	Class II	Terminated	20 Jul 2016
D-1193-2016	HYDROXY B12 1000MCG/ML IN NACL 0.9% (PF), 1ML Vials, MEDAUS PHARMACY	300 mL in Vials	Class II	Terminated	20 Jul 2016
D-1194-2016	L-CARNITINE 100MG/ML (PF), 10ML Vials, MEDAUS PHARMACY	1400 mL in Vials	Class II	Terminated	20 Jul 2016
D-1195-2106	L-CARNITINE 50MG/ML (PF), 10ML Vials, MEDAUS PHARMACY	2000 mL in Vials	Class II	Terminated	20 Jul 2016
D-1196-2016	L-CARNITINE 250MG/ML (PF), 10ML Vials, MEDAUS PHARMACY	2250 mL in Vials	Class II	Terminated	20 Jul 2016
D-1197-2016	L-CARNITINE 500MG/ML (PF), 10ML Vials, MEDAUS PHARMACY	500 mL in Vials	Class II	Terminated	20 Jul 2016
D-1198-2016	L-GLUTATHIONE 100MG/ML (PF), 10 ML Vials, MEDAUS PHARMACY	5000 mL in Vials	Class II	Terminated	20 Jul 2016
D-1199-2016	L-PHENYLALANINE 15MG/ML (PF), 50ML Vials, MEDAUS PHARMACY	55 mL in Vials	Class II	Terminated	20 Jul 2016
D-1200-2016	LIDOCAINE 2% (PF) IN NACL, 10ML Vials, MEDAUS PHARMACY	147 mL in Vials	Class II	Terminated	20 Jul 2016
D-1201-2016	LIPO W/LIDOCAINE #3 W/PRES. (BENZYL ETOH 2%) ASCORBIC ACID 50MG; B1-50MG;B2-5-P04-5MG;D3-30MG; B5-5MG;B6-5MG;CYANO B12-1MG; METHIONINE 12.5MG; INOSITOL-25MG; CHOLINE CL-25 MG; LIDOCAINE 10MG/ML, In a) 5 ML Vials and b) 10ML Vials, MEDAUS PHARMACY	7000 mL in Vials	Class II	Terminated	20 Jul 2016
D-1202-2016	LIPO #4 W/METHYL B12 500 MCG/ML/NO METHIONINE W/PRES (BENZYL ETOH 2%) ASCORBIC ACID 50MG; B1-50MG;B2-5-P04-5MG;B3-30MG; B5-5MG;B6-5MG;METHYL B12 500 MCG; LIDOCAINE 10 MG; INOSITOL-25MG; CHOLINE CHL-25 MG/ML; 5ML Vials, MEDAUS PHARMACY	1000 mL in Vials	Class II	Terminated	20 Jul 2016
D-1203-2016	LIPO-INJECTION W/LIDOCAINE (PF), ASCORBIC ACID 50MG; B1-50MG; B2-5-PO4-5MG; B3-50MG B5-5MG, B6-5MG, CYANO B-12-100MCG, METHIONINE 12.5 MG, INOSITOL 25 MG, CHOLINE CL-25 MG, LIDCAINE 10 MG/ML, 2ML Vials, MEDAUS PHARMACY	1000 mL in Vials	Class II	Terminated	20 Jul 2016
D-1204-2016	LIPO B CYANO 1MG/ML W/PRES. (BENZYL ETOH 1%) METHIONINE 25MG, INOSITOL 50MG, CHOLINE CHL-50MG, CYANO B-12-100MCG, BENZYL ALCOHOL 1%/ML, In a) 5ML Vials and b) 10ML Vials, MEDAUS PHARMACY	155 mL in Vials	Class II	Terminated	20 Jul 2016
D-1205-2016	LIPO-BOOST W/PRES. (BENZYL ETOH 2%) B1-50MG, B2-5-PO4-2MG, B3-100MG, B5-2MG, B6-52MG, METHYL, B12-500MCG, CARNITINE 50 MG, METHIONINE 12.5MG, INOSITOL 25MG, CHOLINE CHL-25MG, LIDOCAINE 30MG/ML, In a) 3ML Vials and b) 5ML Vials, MEDAUS PHARMACY	65 mL in Vials	Class II	Terminated	20 Jul 2016
D-1206-2016	LIPO-INJECTION W/METHYL B12 1 MG/ML W/PRES. (BENZYL ETOH 2%) ASCORBIC ACID-50MG, B1-50MG, B2-5 PHOS-5MG, B-3-50MG, B5-5MG, B6-5MG, METHYL B12-1MG, LIDOCAINE-10MG, METHIONINE 12.5 MG, INOSITOL 25MG, CHOLINE CHL 25MG/ML, In a) 5ML Vials and b) 10ML Vials, MEDAUS PHARMACY	2000 mL in Vials	Class II	Terminated	20 Jul 2016
D-1207-2016	LIPO-INJECTION W/METHYL B12 500 MCG/ML W/PRES. (BENZYL ETOH 2%) ASCORBIC ACID-50MG, B1-50MG, B2-5 PHOS-5MG, B-3-50MG, B5-5MG, B6-5MG, METHYL B12-500MCG, LIDOCAINE-10MG, METHIONINE 12.5 MG, INOSITOL 25MG, CHOLINE CHL 25MG/ML, In a) 5ML Vials and b) 10ML Vials, MEDAUS PHARMACY	4000 mL in Vials	Class II	Terminated	20 Jul 2016
D-1208-2016	LIPO-INJECTION W/METHYL B12 500 MCG/CARNITINE/NO VIT C W/PRES. (BENZYL ETOH 2%) B1-50MG, B2-5 PHOS-5MG, B-3-50MG, B5-5MG, B6-5MG, METHYL B12-500MCG, LIDOCAINE-10MG, CARNITINE 25MG, METHIONINE 12.5 MG, INOSITOL 25MG, CHOLINE CHL 25MG/ML, In a) 5ML Vials and b) 10ML Vials, MEDAUS PHARMACY	7000 mL in Vials	Class II	Terminated	20 Jul 2016
D-1209-2016	LIPO-INJECTION W/LIDOCAINE NO METHIONINE W/PRES. (BENZYL ETOH 2%) ASCORBIC ACID-50MG, B1-50MG, B2-5 PO4-5MG, B-3-50MG, B5-5MG, B6-5MG, CYANO B12-100MCG,INOSITOL 25MG, CHOLINE CHL-25MG, LIDOCAINE-10MG/ML, 5ML Vials, MEDAUS PHARMACY	4000 mL in Vials	Class II	Terminated	20 Jul 2016
D-1210-2016	LIPO-INJECTION W/LIDOCAINE W/PRES. (BENZYL ETOH 2%) ASCORBIC ACID-50MG, B1-50MG, B2-5 PO4-5MG, B-3-50MG, B5-5MG, B6-5MG, CYANO B12-100MCG, METHIONINE 12.5MG, INOSITOL 25MG, CHOLINE CHL-25MG, LIDOCAINE-10MG/ML, In a) 5ML Vials and b) 10ML Vials, MEDAUS PHARMACY	14000 mL in Vials	Class II	Terminated	20 Jul 2016
D-1211-216	MAGNESIUM CHL 200MG/ML (PF), In a) 5ML Vials and b) 10ML Vials, MEDAUS PHARMACY	5000 mL in Vials	Class II	Terminated	20 Jul 2016
D-1212-2016	MANGANESE CHL 0.1MG/ML PF, 10ML Vials, MEDAUS PHARMACY	1000 mL in Vials	Class II	Terminated	20 Jul 2016
D-1213-2016	MANGANESE SO4 0.1MG/ML (PF), In a) 2MLVials and b) 10ML Vials, MEDAUS PHARMACY	3000 mL in Vials	Class II	Terminated	20 Jul 2016
D-1214-2016	METHYL B12 1000MCG/ML W/PRES (BENZALKONIUM 0.01% IN NACL 0.9%, In a) 2ML Vials, b) 5ML Vials, and c) 10ML Vials, MEDAUS PHARMACY	8020 mL in Vials	Class II	Terminated	20 Jul 2016
D-1215-2016	METHYL B12 1000MCG/ML/PYRIDOXINE 100MG W/PRES. (BENZALKONIUM 0.01%), In a) 1ML Vials and b) 10ML Vials, MEDAUS PHARMACY	20 mL in Vials	Class II	Terminated	20 Jul 2016
D-1216-2016	METHYL B12 10MG/ML (PF) IN NACL 0.9%, 1ML Vials, MEDAUS PHARMACY	1000 mL in Vials	Class II	Terminated	20 Jul 2016
D-1217-2016	METHYL B12 1000MCG/ML IN NACL 0.9% (PF), 2ML Vials, MEDAUS PHARMACY	2000 mL in Vials	Class II	Terminated	20 Jul 2016
D-1218-2016	METHYL B12 5MG/ML (PF) IN NACL 0.9%, 1ML Vials, MEDAUS PHARMACY	600 mL in Vials	Class II	Terminated	20 Jul 2016
D-1219-2016	METHYL B12 10MG/ML W/PRES (BENZALKONIUM 0.01%) IN NACL 0.9%, In a) 1ML Vials, b) 5ML Vials, and c) 10ML Vials, MEDAUS PHARMACY	331 mL in Vials	Class II	Terminated	20 Jul 2016
D-1220-2016	M.I.C. 25/50/50 (PF) METHIONINE 25MG;INOSITOL 50MG;CHOLINE CHL 50MG/ML, In 2ML Vials, MEDAUS PHARMACY	187 mL in Vials	Class II	Terminated	20 Jul 2016
D-1221-2016	M.I.C./B-COMPLEX (PF) B1-50MG;B2-5-PO4-5MG;B3-50MG;B6-5MG; CYANO B12 100MCG; CHOLINE CHL-5MG; INOSITOL-25MG;METHIONINE 12.5MG/ML, 2ML Vials, MEDAUS PHARMACY	3000 mL in Vials	Class II	Terminated	20 Jul 2016
D-1222-2016	M.I.C B-COMPLEX PREMIX W/HYDROXY B12 W/PRES. (BENZALKONIUM 0.01%) HYDROXY B12 1MG; B1 0.833MG; B2 0.083MG; B3 0.833MG, B5 0.083MG, B6 0.083MG, CYANO B12 1.66MCG, METHIONINE 0.208MG, INOSITOL 0.416MG, CHOLINE CL 1.66MG/ML, 10ML Vials, MEDAUS PHARMACY	110 mL in Vials	Class II	Terminated	20 Jul 2016
D-1223-2016	M.I.C B-COMPLEX W/PRES. (BENZYL ETOH 2%) B1-50MG;B2-5-PO4-5MG;B3-50MG;B5-5MG;B6-5MG; CYANO B12 100MCG; CHOLINE CHL-50MG; INOSITOL-25MG;METHIONINE 12.5MG/ML, 5ML Vials, MEDAUS PHARMACY	1430 mL in Vials	Class II	Terminated	20 Jul 2016
D-1224-2016	M.I.C 25/50/50 W/PRES. (BENZYL ETOH 2%) METHIONINE 25MG;INOSITOL 50MG;CHOLINE CHL 50/MG/ML, In a) 5ML Vials and b) 10ML Vials, MEDAUS PHARMACY	500 mL in Vials	Class II	Terminated	20 Jul 2016
D-1225-2016	M.I.C 25/50/50 W/METHYL B12 1MG/PYRIDOXAL 50MG/ML (PF), 1ML Vials, MEDAUS PHARMACY	2000 mL in Vials	Class II	Terminated	20 Jul 2016
D-1226-2016	MINOXIDIL 0.5% W/PRES. (BENZYL ETOH 2%), 10ML Vials, MEDAUS PHARMACY	21000 mL in Vials	Class II	Terminated	20 Jul 2016

The table shows 60 of 88 product records. The FDA enforcement report lists all the records.

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class II: The middle of the three FDA recall classes.

The event in context

Drug events that started in 2016: 288
Share of these events in Class II: 46%
Product records in this event: 88Median of the firm: 88
Events of the firm on the register: 2

Other events of the firm

Other FDA enforcement events of Medaus, Inc.
Initiated	Product (first record)	Type	Class	Records
23 Aug 2013	Testosterone Cyp 200 mg/mL, W/Pres. (Benzyl ETOH), 3 mL, Medaus pharmacy 1-800-526-9183	Drug	Class II	8

Official channels

FDA enforcement report D-1167-2016The FDA record of the first product of this event.
FDA: recalls, market withdrawals and safety alertsThe recall notices on the FDA site.
FDA MedWatchThe FDA safety reporting program for drugs and medical devices.

Follow by RSS:Food, drug and device recallsFDA Class I recalls

Cite this page

Recall Register. FDA enforcement event 74466. https://recallregister.com/fda/ii/74466/. Source: openFDA enforcement reports. Data through 28 Sep 2026.

Sources

Source: openFDA drug enforcement reports
Licence: CC0 1.0
Export date: 28 Sep 2026
Newest FDA report date on the register: 23 Sep 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?: The FDA record gives this distribution: U.S. Nationwide, Japan, and New Zealand.
What quantity of product is in FDA event 74466?: The event has 88 product records. The first record gives this quantity: 1000 mL in Vials
How did the recall start?: The FDA record says: Voluntary: Firm initiated
How many drug recalls of 2016 have the same class?: 46% of the 288 drug events that started in 2016 are in Class II.